|Last Price||Today's Change||52-Week Range||Trading Volume|
|2.38||-0.09 (-3.64%)||2.37 - 7.22||806.2 thousand (Below Avg)|
Market data as of 4:00PM 01/30/15. Quotes are delayed by at least 15 min.
Synta Announces Presentation of Results from an Investigator-Sponsored Phase 1 Trial of Ganetespib in HER2+ Metastatic Breast Cancer at the 2014 San Antonio Breast Cancer Symposium
12/12/2014 8:00 AM ET
Synta Strengthens Management Team with Two Executive Appointments
12/04/2014 4:30 PM ET